Mukka Proteins Limited (MUKKA) - Net Assets
Based on the latest financial reports, Mukka Proteins Limited (MUKKA) has net assets worth Rs4.62 Billion INR (≈ $49.99 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs12.39 Billion ≈ $134.02 Million USD) and total liabilities (Rs7.77 Billion ≈ $84.03 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Mukka Proteins Limited's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs4.62 Billion |
| % of Total Assets | 37.3% |
| Annual Growth Rate | 47.62% |
| 5-Year Change | 552.85% |
| 10-Year Change | N/A |
| Growth Volatility | 59.99 |
Mukka Proteins Limited - Net Assets Trend (2019–2025)
This chart illustrates how Mukka Proteins Limited's net assets have evolved over time, based on quarterly financial data. Also explore Mukka Proteins Limited assets under control for the complete picture of this company's asset base.
Annual Net Assets for Mukka Proteins Limited (2019–2025)
The table below shows the annual net assets of Mukka Proteins Limited from 2019 to 2025. For live valuation and market cap data, see Mukka Proteins Limited (MUKKA) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs4.57 Billion ≈ $49.37 Million |
+11.80% |
| 2024-03-31 | Rs4.08 Billion ≈ $44.16 Million |
+187.67% |
| 2023-03-31 | Rs1.42 Billion ≈ $15.35 Million |
+49.58% |
| 2022-03-31 | Rs948.89 Million ≈ $10.26 Million |
+35.70% |
| 2021-03-31 | Rs699.24 Million ≈ $7.56 Million |
+21.08% |
| 2020-03-31 | Rs577.51 Million ≈ $6.25 Million |
+30.96% |
| 2019-03-31 | Rs440.98 Million ≈ $4.77 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Mukka Proteins Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 485.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs2.26 Billion | 51.31% |
| Common Stock | Rs300.00 Million | 6.81% |
| Other Comprehensive Income | Rs-3.27 Million | -0.07% |
| Other Components | Rs1.85 Billion | 41.96% |
| Total Equity | Rs4.41 Billion | 100.00% |
Mukka Proteins Limited Competitors by Market Cap
The table below lists competitors of Mukka Proteins Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ganesh Benzoplast Limited
NSE:GANESHBE
|
$78.00 Million |
|
Trans Polonia S.A.
WAR:TRN
|
$78.03 Million |
|
Anam Electroni
KO:008700
|
$78.03 Million |
|
Popular Vehicles and Services Limited
NSE:PVSL
|
$78.08 Million |
|
APS Holdings Corporation
KQ:054620
|
$77.96 Million |
|
PGF Capital Bhd
KLSE:8117
|
$77.95 Million |
|
All Cosmos Bio-Tech Holding Corp
TW:4148
|
$77.95 Million |
|
Rangdong Light source and Vacuum flask JSC
VN:RAL
|
$77.92 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mukka Proteins Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,960,900,000 to 4,407,030,000, a change of 446,130,000 (11.3%).
- Net income of 464,590,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 1,847,849,999.
- Other factors increased equity by 1,829,389,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs464.59 Million | +10.54% |
| Other Comprehensive Income | Rs-1.85 Billion | -41.93% |
| Other Changes | Rs1.83 Billion | +41.51% |
| Total Change | Rs- | 11.26% |
Book Value vs Market Value Analysis
This analysis compares Mukka Proteins Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.63x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 16.39x to 1.63x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-03-31 | Rs1.47 | Rs24.03 | x |
| 2020-03-31 | Rs1.89 | Rs24.03 | x |
| 2021-03-31 | Rs2.22 | Rs24.03 | x |
| 2022-03-31 | Rs4.08 | Rs24.03 | x |
| 2023-03-31 | Rs6.07 | Rs24.03 | x |
| 2024-03-31 | Rs17.53 | Rs24.03 | x |
| 2025-03-31 | Rs14.70 | Rs24.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mukka Proteins Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.54%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.62%
- • Asset Turnover: 0.94x
- • Equity Multiplier: 2.44x
- Recent ROE (10.54%) is below the historical average (22.49%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 32.49% | 3.61% | 1.97x | 4.57x | Rs98.91 Million |
| 2020 | 23.30% | 2.48% | 1.82x | 5.18x | Rs75.21 Million |
| 2021 | 13.49% | 1.52% | 1.66x | 5.34x | Rs23.24 Million |
| 2022 | 26.95% | 3.16% | 1.95x | 4.37x | Rs152.26 Million |
| 2023 | 32.98% | 3.81% | 2.01x | 4.30x | Rs307.12 Million |
| 2024 | 17.69% | 5.08% | 1.47x | 2.38x | Rs304.43 Million |
| 2025 | 10.54% | 4.62% | 0.94x | 2.44x | Rs23.89 Million |
Industry Comparison
This section compares Mukka Proteins Limited's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $21,473,155,939
- Average return on equity (ROE) among peers: 13.83%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mukka Proteins Limited (MUKKA) | Rs4.62 Billion | 32.49% | 1.68x | $77.96 Million |
| ADF Foods Limited (ADFFOODS) | $1.01 Billion | 13.22% | 0.18x | $313.83 Million |
| Ajooni Biotech Limited (AJOONI) | $416.69 Million | 2.70% | 0.41x | $7.82 Million |
| Agro Tech Foods Limited (ATFL) | $964.98 Million | 14.49% | 0.70x | $365.36 Million |
| Avanti Feeds Limited (AVANTIFEED) | $668.96 Million | -1.80% | 0.71x | $2.03 Billion |
| Adani Wilmar Limited (AWL) | $81.66 Billion | 7.13% | 1.57x | $2.75 Billion |
| Bombay Burmah Trading Corporation Limited (BBTC) | $56.67 Billion | 4.90% | 0.48x | $1.13 Billion |
| Mrs. Bectors Food Specialities Limited (BECTORFOOD) | $5.44 Billion | 16.55% | 0.53x | $650.88 Million |
| Bikaji Foods International Limited (BIKAJI) | $14.81 Billion | 13.57% | 0.31x | $1.83 Billion |
| Britannia Industries Limited (BRITANNIA) | $43.81 Billion | 49.73% | 1.02x | $14.92 Billion |
| CCL Products (India) Limited (CCL) | $9.28 Billion | 17.87% | 0.63x | $1.64 Billion |
About Mukka Proteins Limited
Mukka Proteins Limited manufactures and sells fish protein products in India. The company offers fish meal, oil, and soluble paste; and ento meal, oil, and soil. It also provides insect meal, oil, and compost; and humic acid. The company's products are used for aqua feed, poultry feed, pet feed, EPADHA extraction, animal feed, soap manufacture, leather tanneries, and paint industries. It also exp… Read more